{"entity":{"type":"insider","cik":"0001863107","url":"/insider/0001863107","json_url":"/insider/0001863107.json","name":"Bender Jeremy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":28,"first":"2022-07-06","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Bender Jeremy","source":"filing","n_filings":28,"first_seen":"2022-07-06","last_seen":"2026-02-18"}],"transactions":[{"id":5806537,"accession":"0001863107-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001863107-26-000004","line_url":"/filing/0001863107-26-000004#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15459.0,"shares_display":"15,459","price_per_share":11.6009,"price_display":"11.60","price_state":"stated","total_value":179338.3131,"total_display":"179,338.31","total_whole":"179,338","shares_owned_after":204603.0,"shares_owned_after_display":"204,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider"},{"id":4779750,"accession":"0001863107-25-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001863107-25-000005","line_url":"/filing/0001863107-25-000005#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15894.0,"shares_display":"15,894","price_per_share":8.9147,"price_display":"8.91","price_state":"stated","total_value":141690.2418,"total_display":"141,690.24","total_whole":"141,690","shares_owned_after":177165.0,"shares_owned_after_display":"177,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":4558964,"accession":"0001415889-25-022380","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-022380","line_url":"/filing/0001415889-25-022380#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16058.0,"shares_display":"16,058","price_per_share":6.7671,"price_display":"6.77","price_state":"stated","total_value":108666.0918,"total_display":"108,666.09","total_whole":"108,666","shares_owned_after":161365.0,"shares_owned_after_display":"161,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4051028,"accession":"0001415889-25-013676","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-013676","line_url":"/filing/0001415889-25-013676#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13964.0,"shares_display":"13,964","price_per_share":6.2579,"price_display":"6.26","price_state":"stated","total_value":87385.3156,"total_display":"87,385.32","total_whole":"87,385","shares_owned_after":145737.0,"shares_owned_after_display":"145,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4860520,"accession":"0001415889-25-005154","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-005154","line_url":"/filing/0001415889-25-005154#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12048.0,"shares_display":"12,048","price_per_share":11.963,"price_display":"11.96","price_state":"stated","total_value":144130.224,"total_display":"144,130.22","total_whole":"144,130","shares_owned_after":128015.0,"shares_owned_after_display":"128,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-21","scope":"insider"},{"id":2257520,"accession":"0001415889-24-027239","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027239","line_url":"/filing/0001415889-24-027239#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10554.0,"shares_display":"10,554","price_per_share":13.2102,"price_display":"13.21","price_state":"stated","total_value":139420.4508,"total_display":"139,420.45","total_whole":"139,420","shares_owned_after":108377.0,"shares_owned_after_display":"108,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2900382,"accession":"0001415889-24-021617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-021617","line_url":"/filing/0001415889-24-021617#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10681.0,"shares_display":"10,681","price_per_share":13.9991,"price_display":"14.00","price_state":"stated","total_value":149524.3871,"total_display":"149,524.39","total_whole":"149,524","shares_owned_after":98932.0,"shares_owned_after_display":"98,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":2929319,"accession":"0001415889-24-013620","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-013620","line_url":"/filing/0001415889-24-013620#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7873.0,"shares_display":"7,873","price_per_share":16.0787,"price_display":"16.08","price_state":"stated","total_value":126587.6051,"total_display":"126,587.61","total_whole":"126,588","shares_owned_after":654728.0,"shares_owned_after_display":"654,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2530033,"accession":"0001415889-24-012255","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-012255","line_url":"/filing/0001415889-24-012255#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9154.0,"shares_display":"9,154","price_per_share":17.852,"price_display":"17.85","price_state":"stated","total_value":163417.208,"total_display":"163,417.21","total_whole":"163,417","shares_owned_after":642602.0,"shares_owned_after_display":"642,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-03","filed_date":"2024-05-03","scope":"insider"},{"id":2530031,"accession":"0001415889-24-012255","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012255","line_url":"/filing/0001415889-24-012255#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6.0,"shares_display":"6","price_per_share":17.9375,"price_display":"17.94","price_state":"stated","total_value":107.625,"total_display":"107.62","total_whole":"108","shares_owned_after":651756.0,"shares_owned_after_display":"651,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2530028,"accession":"0001415889-24-012255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-012255","line_url":"/filing/0001415889-24-012255#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70051.0,"shares_display":"70,051","price_per_share":17.8753,"price_display":"17.88","price_state":"stated","total_value":1252182.6403,"total_display":"1,252,182.64","total_whole":"1,252,183","shares_owned_after":651762.0,"shares_owned_after_display":"651,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":2324727,"accession":"0001415889-24-004452","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-004452","line_url":"/filing/0001415889-24-004452#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7615.0,"shares_display":"7,615","price_per_share":15.2481,"price_display":"15.25","price_state":"stated","total_value":116114.2815,"total_display":"116,114.28","total_whole":"116,114","shares_owned_after":721813.0,"shares_owned_after_display":"721,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":7999964,"accession":"0001209191-23-055879","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-055879","line_url":"/filing/0001209191-23-055879#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3107.0,"shares_display":"3,107","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":36320.83,"total_display":"36,320.83","total_whole":"36,321","shares_owned_after":709429.0,"shares_owned_after_display":"709,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8440279,"accession":"0001209191-23-046409","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046409","line_url":"/filing/0001209191-23-046409#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2996.0,"shares_display":"2,996","price_per_share":13.86,"price_display":"13.86","price_state":"stated","total_value":41524.56,"total_display":"41,524.56","total_whole":"41,525","shares_owned_after":704224.0,"shares_owned_after_display":"704,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-17","scope":"insider"},{"id":8112232,"accession":"0001209191-23-030388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-030388","line_url":"/filing/0001209191-23-030388#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3104.0,"shares_display":"3,104","price_per_share":13.1223,"price_display":"13.12","price_state":"stated","total_value":40731.6192,"total_display":"40,731.62","total_whole":"40,732","shares_owned_after":1179484.0,"shares_owned_after_display":"1,179,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8392466,"accession":"0001209191-23-017295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017295","line_url":"/filing/0001209191-23-017295#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.0091,"price_display":"20.01","price_state":"stated","total_value":250113.75,"total_display":"250,113.75","total_whole":"250,114","shares_owned_after":1174276.0,"shares_owned_after_display":"1,174,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":7896510,"accession":"0001209191-23-010802","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-010802","line_url":"/filing/0001209191-23-010802#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3022.0,"shares_display":"3,022","price_per_share":19.573,"price_display":"19.57","price_state":"stated","total_value":59149.606,"total_display":"59,149.61","total_whole":"59,150","shares_owned_after":1186776.0,"shares_owned_after_display":"1,186,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":7867450,"accession":"0001209191-23-004654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004654","line_url":"/filing/0001209191-23-004654#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":21.999,"price_display":"22.00","price_state":"stated","total_value":274987.5,"total_display":"274,987.50","total_whole":"274,988","shares_owned_after":1181486.0,"shares_owned_after_display":"1,181,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-24","scope":"insider"},{"id":6993513,"accession":"0001209191-22-062493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062493","line_url":"/filing/0001209191-22-062493#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.3175,"price_display":"20.32","price_state":"stated","total_value":253968.75,"total_display":"253,968.75","total_whole":"253,969","shares_owned_after":1192424.0,"shares_owned_after_display":"1,192,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6278919,"accession":"0001209191-22-058490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058490","line_url":"/filing/0001209191-22-058490","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.7583504,"price_display":"20.76","price_state":"stated","total_value":259479.38,"total_display":"259,479.38","total_whole":"259,479","shares_owned_after":1205324.0,"shares_owned_after_display":"1,205,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider","n_lines":2},{"id":6150218,"accession":"0001209191-22-057626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-057626","line_url":"/filing/0001209191-22-057626#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1513.0,"shares_display":"1,513","price_per_share":21.4598,"price_display":"21.46","price_state":"stated","total_value":32468.6774,"total_display":"32,468.68","total_whole":"32,469","shares_owned_after":1217424.0,"shares_owned_after_display":"1,217,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":6253170,"accession":"0001209191-22-055562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055562","line_url":"/filing/0001209191-22-055562#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.0284,"price_display":"20.03","price_state":"stated","total_value":250355.0,"total_display":"250,355.00","total_whole":"250,355","shares_owned_after":1215375.0,"shares_owned_after_display":"1,215,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6613647,"accession":"0001209191-22-052743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052743","line_url":"/filing/0001209191-22-052743#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.0517,"price_display":"20.05","price_state":"stated","total_value":250646.25,"total_display":"250,646.25","total_whole":"250,646","shares_owned_after":1227875.0,"shares_owned_after_display":"1,227,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6548275,"accession":"0001209191-22-048896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048896","line_url":"/filing/0001209191-22-048896","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":23.246446952,"price_display":"23.25","price_state":"stated","total_value":290580.5869,"total_display":"290,580.59","total_whole":"290,581","shares_owned_after":1242234.0,"shares_owned_after_display":"1,242,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":6212314,"accession":"0001209191-22-048897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048897","line_url":"/filing/0001209191-22-048897","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":23.246446952,"price_display":"23.25","price_state":"stated","total_value":290580.5869,"total_display":"290,580.59","total_whole":"290,581","shares_owned_after":1242234.0,"shares_owned_after_display":"1,242,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":6893332,"accession":"0001209191-22-046483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046483","line_url":"/filing/0001209191-22-046483#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4003.0,"shares_display":"4,003","price_per_share":24.31,"price_display":"24.31","price_state":"stated","total_value":97312.93,"total_display":"97,312.93","total_whole":"97,313","shares_owned_after":1252875.0,"shares_owned_after_display":"1,252,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":6612954,"accession":"0001209191-22-044600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044600","line_url":"/filing/0001209191-22-044600#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.0017,"price_display":"20.00","price_state":"stated","total_value":250021.25,"total_display":"250,021.25","total_whole":"250,021","shares_owned_after":1246192.0,"shares_owned_after_display":"1,246,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6305117,"accession":"0001209191-22-042762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042762","line_url":"/filing/0001209191-22-042762#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":20.0012,"price_display":"20.00","price_state":"stated","total_value":52003.12,"total_display":"52,003.12","total_whole":"52,003","shares_owned_after":1258692.0,"shares_owned_after_display":"1,258,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6430537,"accession":"0001209191-22-041976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041976","line_url":"/filing/0001209191-22-041976#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1795.0,"shares_display":"1,795","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":35900.0,"total_display":"35,900.00","total_whole":"35,900","shares_owned_after":1261292.0,"shares_owned_after_display":"1,261,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-12","scope":"insider"},{"id":6148998,"accession":"0001209191-22-041406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-041406","line_url":"/filing/0001209191-22-041406#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":857.0,"shares_display":"857","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":17140.0,"total_display":"17,140.00","total_whole":"17,140","shares_owned_after":1263087.0,"shares_owned_after_display":"1,263,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6148994,"accession":"0001209191-22-041406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041406","line_url":"/filing/0001209191-22-041406#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863107","owner_name":"Bender Jeremy","owner_display_name":"Bender Jeremy","owner_url":"/insider/0001863107","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1746.0,"shares_display":"1,746","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":34920.0,"total_display":"34,920.00","total_whole":"34,920","shares_owned_after":1263944.0,"shares_owned_after_display":"1,263,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":28,"first_seen":"2022-07-06","last_seen":"2026-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001863107","retrieved_at":"2026-08-26T05:02:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}